Earlier today, Governor Andrew M. Cuomo
announced that the Buffalo-based Roswell Park Cancer Institute will
launch a groundbreaking clinical trial of CIMAvax-EGF – a
Cuban-developed lung cancer treatment. The announcement comes on the
heels of Governor Cuomo’s landmark trade mission to Cuba last year,
where he facilitated and secured the first-in-the-nation partnership
between Roswell Park and the Havana-based Center of Molecular
Immunology. The joint venture makes Roswell Park the first medical
institution to receive FDA permission to sponsor testing of a Cuban
medical therapy in the United States. The new study – which is the
culmination of formal agreements between state, federal and Cuban
officials during the historic 2015 trade mission – is expected to begin
in November. More information is available here.
The letter from Cuban Ambassador José Ramón Cabañas Rodríguez congratulating Governor Cuomo on the historic partnership is available here.
A video detailing cancer treatment’s impacts is available here.
Source: Press Office, Governor Andrew M. Cuomo
No comments:
Post a Comment